BioLife Solutions Sets Date for Annual Meeting of Stockholders
PR Newswire - Wed Dec 24, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Names Pharmaceutical Industry Expert Kevin O'Donnell as Vice President, Cold Chain Standards, Practices & Compliance
PR Newswire - Tue Dec 23, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:45AM CST
GLOG: 20.40 (-0.98), MILL: 1.23 (-0.07), LPHI: 0.70 (+0.02), NEOT: 6.65 (+0.25), BOBE: 50.58 (-0.04), FES: 1.19 (-0.01), REDF: 2.09 (unch), NKTR: 15.02 (+0.23), PRTO: 10.40 (+0.17), CANF: 3.70 (+0.01), CALI: 1.19 (+0.05), TRT: 2.92 (unch), SQNM: 3.59 (-0.01), CARB: 14.54 (+0.94), SEED: 1.33 (-0.03), BLFS: 1.79 (-0.02), DGLY: 15.62 (+0.82), TCCO: 4.96 (-0.04), ALCO: 49.88 (-0.50), PBYI: 189.96 (+0.12)
BioLife Solutions to Present at the LD Micro "Main Event" Investor Conference on Wednesday, December 3, 2014
PR Newswire - Tue Nov 25, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BUYINS.NET Issues BioLife Solutions (BLFS) SqueezeTrigger Report
M2 - Mon Nov 24, 7:09AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated trading coverage on BioLife Solutions, Inc., (NASDAQ: BLFS) after releasing the latest short sale data through November 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.4 million shares, adjusted for a 1 for 14 reverse split that occurred on January 29, 2014. Approximately 26.04% of daily trading volume is short selling. The SqueezeTrigger price for all BLFS shares shorted is $3.29. A short squeeze is expected to begin when shares of BLFS close above the $3.29 SqueezeTrigger price.
BLFS: 1.79 (-0.02)
BioLife Solutions Launches Two New Product Packaging Options for BloodStor® and CryoStor® Freeze Media
PR Newswire - Mon Nov 17, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Named to Deloitte's 2014 Technology Fast 500(TM) List of Fastest Growing Companies in North America
PR Newswire - Thu Nov 13, 5:00AM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions' (BLFS) CEO Mike Rice on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 10:23PM CST
BLFS: 1.79 (-0.02)
Update: BioLife Q3 Earnings
Trevor Lowenthal - at Seeking Alpha - Fri Nov 07, 5:00AM CST
BLFS: 1.79 (-0.02)
BioLife Solutions misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:34PM CST
BLFS: 1.79 (-0.02)
BioLife Solutions Announces Third Quarter 2014 Results
PR Newswire - Thu Nov 06, 3:05PM CST
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014
PR Newswire - Thu Oct 30, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced today that the Company's third quarter 2014 financial results will be released on Thursday, November 6, 2014, and that the Company will host a conference call and live webcast at 1:30 p.m. PST that afternoon. Management will provide an overview of the Company's financial results and a general business update.
BLFS: 1.79 (-0.02)
RoosterBio Selects BioLife Solutions CryoStor® to Commercialize Human Bone Marrow-Derived Stem Cells
PR Newswire - Tue Oct 21, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Biopreservation Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy
PR Newswire - Tue Oct 14, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
NBS: 3.27 (+0.02), BLFS: 1.79 (-0.02)
BioLife Solutions Announces Preliminary Revenue for Q3 2014 of $1.2 Million
PR Newswire - Mon Oct 06, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Forms biologistex CCM(SM) Joint Venture with SAVSU® Technologies to Market Intelligent, Controlled Temperature Containers for Biologics
PR Newswire - Tue Sep 30, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board
PR Newswire - Tue Sep 23, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City And The Aegis Healthcare & Technology Conference In Las Vegas
PR Newswire - Mon Sep 08, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions CryoStor® AND HypoThermosol® Now Embedded In 130 Regenerative Medicine Clinical Trials
PR Newswire - Mon Aug 25, 5:00AM CDT
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)
BioLife Solutions Announces Second Quarter 2014 Results
PR Newswire - Thu Aug 07, 3:05PM CDT
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"
BLFS: 1.79 (-0.02)